TD Waterhouse Canada’s Centessa Pharmaceuticals CNTA Stock Holding History

TD Waterhouse Canada’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,595	Closed	-$622K	–	2430
2026 Q1	$622K	Buy	15,595 +14,592	+1,455%	+$373K	﹤0.01%	794
2025 Q4	$25.1K	Buy	+1,003	New	+$25.4K	﹤0.01%	1349

TD Waterhouse Canada's CNTA Position: Q2 2026 in Review

TD Waterhouse Canada sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 15,595 shares — an estimated $622K sold.

TD Waterhouse Canada first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $622K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

TD Waterhouse Canada reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
TD Waterhouse Canada sold 15,595 Centessa Pharmaceuticals shares in Q2 2026, an estimated $622K.
TD Waterhouse Canada first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
TD Waterhouse Canada's Centessa Pharmaceuticals position peaked at $622K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.